Why STAAR Surgical Is Back on Investors’ Radar

STAAR Surgical (STAA) has moved back into focus for many investors after a period of mixed share performance, including a decline over the past week and a gain over the past 3 months.

With the share price at US$28.26, recent trading has been choppy, with the 1-day share price return down 0.81% and the 7-day share price return down 9.97%, but the 90-day share price return of 52.18% and 1-year total shareholder return of 69.53% indicate that momentum has been strong recently, even though the 3-year and 5-year total shareholder returns remain sharply negative.

If STAAR Surgical’s recent swings have you considering where else growth stories could emerge in healthcare, it may be worth scanning 39 healthcare AI stocks.

With STAAR Surgical valued at about US$1.42b and trading close to analyst price targets, the key question for you is simple: is there still upside left here, or is the market already pricing in future growth?

Most Popular Narrative: 4.7% Undervalued

STAAR Surgical’s most followed narrative pegs fair value at about $29.67 per share, just above the last close of $28.26. This frames the recent rally in a specific way.

STAAR Surgical has significant cash reserves and no debt, providing a strong financial base to navigate the current challenges, reduce production outputs temporarily, and invest selectively in growth initiatives, potentially stabilizing earnings and providing upside if conditions improve.

Curious what justifies paying up for a company that is still loss making today? The narrative leans heavily on a sharp earnings swing, rising margins, and a future valuation multiple that assumes investors stay confident in that shift.

Result: Fair Value of $29.67 (UNDERVALUED)

However, there is still real risk here, especially if China demand stays weak for longer or if competitive pressure and cost cuts hit margins harder than expected.

Another Angle on Valuation

The popular narrative leans on future earnings to argue STAAR Surgical is slightly undervalued. Yet today the stock trades on a P/S of 4.8x versus 2.6x for the US Medical Equipment industry, 3.4x for peers, and a fair ratio of 3.3x. This points to meaningful valuation risk if sentiment cools.

Next Steps

If this mix of optimism and caution leaves you undecided, move quickly, review the data for yourself, and weigh up the stock’s 1 key reward.

Looking for more investment ideas?

If STAAR Surgical has caught your attention, do not stop here. Diversify your watchlist and give yourself more options before the next move in the market.

• Scan for potential mispriced opportunities by reviewing companies in the 47 high quality undervalued stocks that pair strong fundamentals with attractive pricing.
• Strengthen the defensive side of your portfolio by focusing on companies highlighted in the 63 resilient stocks with low risk scores to help reduce overall volatility.
• Hunt for future standouts by checking the screener containing 22 high quality undiscovered gems that combine solid financial quality with lower market attention.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.